Study genetics and outcomes in early lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This study looks at your family history and genetic factors to understand how non-small cell lung cancer (a common lung cancer type) behaves over time, especially when diagnosed young. It may help researchers predict outcomes and identify who could benefit from different care in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with primary non-small cell lung cancer
- You were diagnosed before age 45
- At least one close family member (up to third-degree relatives) has been diagnosed with non-small cell lung cancer
- You are not currently being treated with chemotherapy or radiation for another cancer
- You do not have a bleeding/clotting problem (coagulopathy)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for inherited (family-passed) genetic changes that may raise the risk of lung cancer and related thoracic cancers. It may help people and families understand their genetic risk by collecting health information and sometimes specimens from patients and relatives.
This study builds and tests risk prediction tools for lung cancer in people who have never smoked, using information from family history. If it works, it may help doctors identify who might need closer screening earlier.
This study looks at genetic (DNA) and molecular (cell-level) information related to lung cancer to better understand the disease. You may be invited if you have a confirmed primary lung cancer diagnosis, or if you are healthy with no cancer.
This study looks at gene-related information from a lung tumor sample and pairs it with special imaging to better understand non-small cell lung cancer. If you have a confirmed diagnosis and the right samples/tests, this may help researchers match patients to the most useful information for planning treatment.
This study looks at genetic changes in people with suspected or high-risk lung cancer. It aims to use those results to guide more personalized treatment decisions.
This study looks at biological samples from people diagnosed with lung cancer at age 45 or younger. It may help researchers understand how young lung cancers differ, which could guide future treatments.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.